Sacorpenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria for the Experimental Group: Patients with simple sarcopenia: (1) Age 50-70 years old; (2) Those who meet the 2019 criteria for sarcopenia by the Asian Sarcopenia Working Group (AWGS) are: male grip strength =12s; (3) voluntarily join this trial and sign the informed consent form; (4) Those with good compliance. Patients with simple knee osteoarthritis (1) Age 50-70 years old; (2) meet the diagnostic criteria of the American Rheumatology Association KOA, and the Kellgren-Lawrence stage is less than stage IV; (3) Patients with unilateral knee osteoarthritis; (4) voluntarily join this trial and sign the informed consent form; (5) Those with good compliance. Patients with sarcopenia and knee osteoarthritis: (1) Age 50-70 years old; (2) Those who meet the 2019 judgment criteria for sarcopenia by the Asian Sarcopenia Working Group (AWGS): male grip strength =12s; (3) Meet the diagnostic criteria of the American Rheumatology Association KOA, and the Kellgren-Lawrence stage is less than stage IV; (4) Patients with unilateral knee osteoarthritis; (5) Voluntarily join this trial and sign the informed consent form; (6) Those with good compliance. Inclusion Criteria for the Control Group: (1) Age 50-70 years old; (2) Those who are in good health, have no neuroskeletal muscular system diseases or symptoms, and have no other systemic diseases, such as respiratory system, circulatory system, etc.; (3) No history of major trauma or surgery of the lower limbs; (4) does not meet the criteria for sarcopenia; (5) voluntarily join this trial and sign the informed consent form; (6) Those with good compliance.
Exclusion criteria
Exclusion criteria: 1. Severe cardiovascular and cerebrovascular diseases, nervous system diseases; 2. Patients with recent fractures or surgeries; 3. There are implanted items in the body (including but not limited to pacemakers, artificial joints, steel plates, etc.); 4. Patients with severe osteoporosis, mental illness and cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Kinematic stability;Joint laxity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thickness of quadriceps;Thickness of hamstring ;Electromyography; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine